Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07219680 · ClinicalTrials.gov registry record · NA
Intervention for Communication Quality of Life in Primary Progressive Aphasia
A NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA), sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT07219680 is a NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA) that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 25 participants, below the 84-participant average among 5 other Logopenic Progressive Aphasia trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07219680, a NA study of Logopenic Progressive Aphasia and Primary Progressive Aphasia(PPA), is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak English and/or Spanish. The study will also document how acceptable and beneficial the program is to both patients and their care partners. The main questions the study aims to answer are: 1. Is the telerehabilitation program feasible and acceptable for people with PPA and their care partners? 2. Do participants with PPA and care partners find treatment beneficial? 3. Which outcome measures are most useful for evaluating changes in communication and quality of life? 4. What patterns of treatment response are seen in participants after completing the program? The program includes both speech-language therapy and training for care partners. Participants with PPA will: 1. Complete virtual communication tasks and questionnaires before and after the program 2. Take part in online speech-language therapy sessions 3. Include their care partners in some parts of the program for training and support
Conditions Studied
Interventions
- BEHAVIORAL Multicomponent Lexical Retrieval Training
- BEHAVIORAL Multicomponent Video Implemented Script Training in Aphasia
Study Locations (1)
Texas
- University of Texas - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-01-03 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07219680
The ClinicalTrials.gov registry entry for NCT07219680 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 5 other Logopenic Progressive Aphasia trials with a reported enrollment target (70% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Logopenic Progressive Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Multicomponent Lexical Retrieval Training is the first listed.
NCT07219680 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07219680 about?
NCT07219680 is a clinical study titled "Intervention for Communication Quality of Life in Primary Progressive Aphasia". The goal of this clinical trial is to determine whether individually tailored speech-language telerehabilitation helps improve communication in people with primary progressive aphasia (PPA), a form of dementia that affects speech and language. The study will be offered to individuals who speak Engli...
What is the current status of trial NCT07219680?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-01-03. Estimated completion is 2027-08.
What conditions does trial NCT07219680 study?
This clinical trial studies the following conditions: Logopenic Progressive Aphasia, Primary Progressive Aphasia(PPA), Semantic Dementia, Logopenic Progressive Aphasia (LPA), Progressive Aphasia.
What interventions are being tested in trial NCT07219680?
The interventions under investigation include: Multicomponent Lexical Retrieval Training (BEHAVIORAL), Multicomponent Video Implemented Script Training in Aphasia (BEHAVIORAL).
Who is sponsoring clinical trial NCT07219680?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07219680 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Logopenic Progressive Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
RECRUITING · NA
-
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
RECRUITING · NA
-
Treatment for Speech and Language in Primary Progressive Aphasia
ACTIVE NOT RECRUITING · NA
-
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.